Announced Thu, 16 Jul · 12:17 IST
Credit rating assigned to Shilpa Biologicals subsidiary
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹644.65
prior close
₹640.45
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.2-0.1-0.1-3.9-2.9-0.8-5.0-6.3-3.7————
Up moveDown movePending
AI summary
India Ratings assigned IND A+/Stable long-term and IND A1+ short-term ratings to bank loan facilities of about INR 1,250 million for Shilpa Biologicals Pvt Ltd, a material subsidiary of Shilpa Medicare. The rating action is listed as Assigned, meaning the facility has been formally rated.
Likely market impact
Investment grade rating for subsidiary debt facility supports borrowing capacity and reflects strong creditworthiness.